HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New anticoagulants: how to deal with treatment failure and bleeding complications.

Abstract
Conventional anticoagulants have proven efficacy in the management of thromboembolism. Their adverse effects and a narrow therapeutic window, necessitating regular need for monitoring, however, have long been an incentive for the development of safer anticoagulants without compromising efficacy. Over the last decade or so several new parenteral and oral anticoagulants have been launched with efficacy comparable with conventional agents. From fondaparinux to its long acting derivative idraparinux, and the factor Xa inhibitor rivaroxaban to the direct thrombin inhibitor dabigatran, the advent of new anticoagulants is radically changing anticoagulation. For conventional anticoagulants, despite their shortcomings, effective methods of reversing their anticoagulant effects exist. Moreover, strategies to deal with the occurrence of fresh thrombotic events in the face of therapeutic anticoagulation with the conventional agents have also been addressed. Nevertheless, for the new anticoagulants, the optimal management of these complications remains unknown. This review explores these issues in the light of current evidence.
AuthorsRashid S Kazmi, Bashir A Lwaleed
JournalBritish journal of clinical pharmacology (Br J Clin Pharmacol) Vol. 72 Issue 4 Pg. 593-603 (Oct 2011) ISSN: 1365-2125 [Electronic] England
PMID21752066 (Publication Type: Journal Article, Review)
Copyright© 2011 The Authors. British Journal of Clinical Pharmacology © 2011 The British Pharmacological Society.
Chemical References
  • Anticoagulants
  • Benzimidazoles
  • Morpholines
  • Thiophenes
  • beta-Alanine
  • Rivaroxaban
  • Dabigatran
Topics
  • Anticoagulants (adverse effects)
  • Benzimidazoles (adverse effects)
  • Dabigatran
  • Hemorrhage (chemically induced)
  • Humans
  • Morpholines (adverse effects)
  • Rivaroxaban
  • Thiophenes (adverse effects)
  • Thromboembolism (drug therapy)
  • Thrombosis (drug therapy)
  • Treatment Failure
  • beta-Alanine (adverse effects, analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: